@article{8959526706a2407680a4d0c7358fb317,
title = "Impacts of anticancer drug parity laws on mortality rates",
abstract = "This study investigates the impacts of anticancer drug parity laws on mortality rates in the United States using a difference-in-differences approach. Using data from 2004 to 2017 Compressed Mortality Files, we show that the anticancer drug parity laws reduce the mortality rate for head/neck malignant cancers but have no impact on malignant cancers of other types. We also rule out an insurance expansion channel that may influence the relationship between anticancer drug parity laws and malignant cancer mortality. Our results are robust to various specifications and falsification tests. Our findings imply that providing equal access to oral anticancer drugs is an effective tool for the prevention of premature mortality.",
keywords = "Anticancer drugs, Cancer treatment, Difference-in-differences approach, Drug insurance, Parity law",
author = "Yichen Shen and Haruko Noguchi",
note = "Funding Information: First of all, we deeply appreciate the two anonymous reviewers of Social Science & Medicine for their excellent comments which greatly help improving the clarify of the paper. We also would like to thank the comments from Yuta Toyama, Akira Kawamura, Rong Fu, Cheolmin Kang, Shuhei Kaneko, Yuichi Watanabe, Sen Zeng, and Shuji Kitahara at the seminar of Waseda University. Further, we would like to express our appreciations for the meaningful comments and suggestions provided by the participants at the International Health Economics Association (iHEA), Basel, Switzerland, and the Japanese Economics Association, Kobe, Japan. This study was supported financially by the Waseda University Research Initiatives funding of an investigation entitled Empirical and theoretical research for social welfare in sustainable society- Inheritance of human capital beyond {\textquoteleft}an individual{\textquoteright} and {\textquoteleft}a generation{\textquoteright} (PI: Haruko Noguchi). It was also supported by the Grant-in-Aid for Scientific Research Project funded by the Ministry of Health, Labour and Welfare (MHLW) toward an investigation entitled: Effects of the prevention policy of lifestyle-related disease on labor productivity and macroeconomy from viewpoint of cost-effective analysis (PI: Haruko Noguchi). The views and opinions expressed by the independent authors in this article are provided in their capacity and are their sole responsibility. All errors in this paper are the authors' own. Funding Information: First of all, we deeply appreciate the two anonymous reviewers of Social Science & Medicine for their excellent comments which greatly help improving the clarify of the paper. We also would like to thank the comments from Yuta Toyama, Akira Kawamura, Rong Fu, Cheolmin Kang, Shuhei Kaneko, Yuichi Watanabe, Sen Zeng, and Shuji Kitahara at the seminar of Waseda University. Further, we would like to express our appreciations for the meaningful comments and suggestions provided by the participants at the International Health Economics Association (iHEA), Basel, Switzerland, and the Japanese Economics Association, Kobe, Japan. This study was supported financially by the Waseda University Research Initiatives funding of an investigation entitled Empirical and theoretical research for social welfare in sustainable society- Inheritance of human capital beyond {\textquoteleft}an individual{\textquoteright} and {\textquoteleft}a generation{\textquoteright} (PI: Haruko Noguchi). It was also supported by the Grant-in-Aid for Scientific Research Project funded by the Ministry of Health, Labour and Welfare (MHLW) toward an investigation entitled: Effects of the prevention policy of lifestyle-related disease on labor productivity and macroeconomy from viewpoint of cost-effective analysis (PI: Haruko Noguchi). The views and opinions expressed by the independent authors in this article are provided in their capacity and are their sole responsibility. All errors in this paper are the authors' own. Publisher Copyright: {\textcopyright} 2021 Elsevier Ltd",
year = "2021",
month = mar,
doi = "10.1016/j.socscimed.2021.113714",
language = "English",
volume = "272",
journal = "Ethics in Science and Medicine",
issn = "0277-9536",
publisher = "Elsevier Limited",
}
